Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

BCR-ABL fusion protein (b3a2)-HLA DR9

Name
BCR-ABL fusion protein (b3a2)-HLA DR9
Molecular structural formula
Normal/Tumor
chronic myeloid leukemia
chronic myeloid leukemia
HLA
DR9(用于人类白细胞抗原 II类)
DR9(用于人类白细胞抗原 II类)
HLA%
3
3
Peptide Sequence
ATGFKQSSKALQRPVAS(其中"KALQRPVAS"为独特抗原突变所导致的修饰残基)
ATGFKQSSKALQRPVAS(其中"KALQRPVAS"为独特抗原突变所导致的修饰残基)
Position
920-936
Lymphocyte Stimulation
peptide
References
[1].Makita M, Azuma T, Hamaguchi H, Niiya H, Kojima K, Fujita S, Tanimoto M, Harada M, Yasukawa M. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes. Leukemia. 2002 Dec, 16(12):2400-7. (PMID: 1245474)
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download